Suppr超能文献

口服甘露糖会改变小鼠器官中脱氨神经氨酸(KDN)的表达水平。

Oral ingestion of mannose alters the expression level of deaminoneuraminic acid (KDN) in mouse organs.

作者信息

Go Shinji, Sato Chihiro, Furuhata Kimio, Kitajima Ken

机构信息

Bioscience and Biotechnology Center, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.

出版信息

Glycoconj J. 2006 Jul;23(5-6):411-21. doi: 10.1007/s10719-006-6734-z.

Abstract

Deaminoneuraminic acid (KDN) is a unique member of the sialic acid family. We previously demonstrated that free KDN is synthesized de novo from mannose as its precursor sugar in trout testis, and that the amount of intracellular KDN increases in mouse B16 melanoma cells cultured in mannose-rich media [Angata et al. (1999) J. Biol. Chem. 274, 22949-56; Angata et al. (1999) Biochem. Biophys. Res. Commun. 261, 326-31]. In the present study, we first demonstrated a mannose-induced increase in intracellular KDN in various cultured mouse and human cell lines. These results led us to examine whether KDN expression in mouse organs is altered by exogenously administered mannose. Under normal feeding conditions, intracellular free KDN was present at very low levels (19-48 pmol/mg protein) in liver, spleen, and lung, and was not detected in kidney or brain. Oral ingestion of mannose, both short-term (90 min) and long-term (2 wk), resulted in an increase of intracellular KDN up to 60-81 pmol/mg protein in spleen and lung and 6.9-18 pmol/mg protein in kidney and brain; however, no change was observed in liver. The level of KDN in organs appears not to be determined only by the KDN 9-phosphate synthase activity, but might also be affected by other enzymes that utilize mannose 6-phosphate as a substrate as well as the enzymes that breakdown KDN, like KDN-pyruvate lyase. In blood, the detectable amount of free KDN did not change on oral ingestion of mannose. These findings indicate that mannose in the diet affects KDN metabolism in various organs, and provide clues to the mechanism of altered KDN expression in some tumor cells and aged organs.

摘要

脱氨神经氨酸(KDN)是唾液酸家族中的一个独特成员。我们之前证明,游离的KDN在 trout 睾丸中由甘露糖作为其前体糖从头合成,并且在富含甘露糖的培养基中培养的小鼠 B16 黑色素瘤细胞中,细胞内 KDN 的量会增加[安加塔等人(1999 年)《生物化学杂志》274 卷,22949 - 56 页;安加塔等人(1999 年)《生物化学与生物物理研究通讯》261 卷,326 - 31 页]。在本研究中,我们首先证明了在各种培养的小鼠和人类细胞系中,甘露糖会诱导细胞内 KDN 增加。这些结果促使我们研究外源性给予甘露糖是否会改变小鼠器官中 KDN 的表达。在正常喂养条件下,肝脏、脾脏和肺中细胞内游离 KDN 的含量非常低(19 - 48 pmol/mg 蛋白质),在肾脏或大脑中未检测到。短期(90 分钟)和长期(2 周)口服甘露糖会导致脾脏和肺中细胞内 KDN 增加至 60 - 81 pmol/mg 蛋白质,肾脏和大脑中增加至 6.9 - 18 pmol/mg 蛋白质;然而,肝脏中未观察到变化。器官中 KDN 的水平似乎不仅由 KDN 9 - 磷酸合酶活性决定,还可能受到其他以甘露糖 6 - 磷酸为底物的酶以及分解 KDN 的酶(如 KDN - 丙酮酸裂解酶)的影响。在血液中,口服甘露糖后可检测到的游离 KDN 量没有变化。这些发现表明饮食中的甘露糖会影响各种器官中的 KDN 代谢,并为某些肿瘤细胞和衰老器官中 KDN 表达改变的机制提供了线索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验